𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Role of μ -opioid receptor in modulation of preproenkephalin mRNA expression and opioid and dopamine receptor binding in methamphetamine-sensitized mice

✍ Scribed by Lu-Tai Tien; Ing-Kang Ho; Horace H. Loh; Tangeng Ma


Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
126 KB
Volume
85
Category
Article
ISSN
0360-4012

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

We examined mRNA expression of preproenkephalin (PPE), a precursor of the endogenous opioid peptide enkephalin, and ligand binding to opioid and dopamine receptors in the striatum and nucleus accumbens in methamphetamine (METH)‐sensitized μ‐opioid receptor (μ‐OR) knockout mice and their wild‐type controls. Animals received daily intraperitoneal (i.p.) injections of METH (0, 0.625, 2.5, or 10 mg/kg) for 7 consecutive days to induce sensitization. Brain tissues were taken for biochemical analysis on experimental day 11 (4 days after the last injection). Expression of PPE mRNA and ligand binding were determined by in situ hybridization and autoradiography, respectively. Results indicate that there is an increase in PPE mRNA expression and a decrease in μ‐OR ligand binding in METH‐sensitized wild‐type mice. These changes were not detected in METH‐sensitized μ‐OR knockout mice. A significant increase in δ‐opioid receptor (δ‐OR) ligand binding was found in μ‐OR knockout mice. After repeated METH exposure, striatal and nucleus accumbal dopamine D1 receptor binding was decreased in μ‐OR knockout mice but was not changed in wild‐type mice. D2 receptor ligand binding was increased in wild‐type mice and exhibited a biphasic change, with a decrease at 0.625 and 2.5 mg/kg doses of METH and an increase with 10 mg/kg of METH, in μ‐OR knockout mice. These findings suggest that the μ‐OR is involved in the regulation of METH‐induced changes in an endogenous opioid peptide and dopamine receptors. © 2006 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Opioid peptide receptor studies, 11: Inv
✍ Heng Xu; Yi-Feng Lu; John S. Partilla; Qiao-Xi Zheng; Jia-Bei Wang; George A. Br 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB 👁 1 views

Previous data obtained with the cloned rat µ opioid receptor demonstrated that the ''super-potent'' opiates, ohmefentanyl (RTI-4614-4) and its four enantiomers, differ in binding affinity, potency, efficacy, and intrinsic efficacy. Molecular modeling (Tang et al., 1996) of fentanyl derivatives bindi

In vivo regulation of μ-opioid receptor
✍ Alokesh Duttaroy; Byron C. Yoburn 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

Chronic in vivo treatment with the opioid agonist etorphine downregulates mu-opioid receptor density, produces tolerance, and regulates gene expression in the mouse. After cessation of treatment, there is an increase in mu-opioid receptor mRNA level associated with the recovery of mu-opioid receptor

Ontogeny of the opioid growth factor, [M
✍ Yan Wu; Patricia J. Mclaughlin; Ian S. Zagon 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 875 KB

Opioid peptides are known to play a role in the function of the mammalian cardiovascular system in the newborn. To learn about mechanisms underlying the morphogenesis of the developing vasculature and the principles contributing to the organization and maintenance of adult blood vessels, we have inv